GHK-Cu Peptide Injection: 2006 Research Data, Industry Growth, and Product Comparison Guide

Core Molecular Specs & Technical Index

The ghk cu peptide injection is a precisely formulated solution containing the copper-binding tripeptide glycyl-L-histidyl-L-lysine. As a B2B raw material, it is defined by its molecular weight of 340.38 g/mol and a sequence that binds one copper ion per molecule. Buyers in cosmetic formulation and laboratory research sectors prioritize this compound for its documented role in cellular signaling and extracellular matrix support. The core value lies in its high-purity, stable formulation that ensures reproducible results in clinical-grade applications.

• Purity Grade: Minimum 98% peptide content by HPLC analysis, with leading manufacturers offering 99%+ for research-grade injections.
• Solubility Profile: Fully soluble in sterile water for injection (WFI) at concentrations up to 50 mg/mL, forming a clear blue solution indicative of copper coordination.
• Stability Parameters: Lyophilized powder remains stable for 24 months at -20°C; reconstituted solution must be used within 72 hours when stored at 2-8°C.
• Endotoxin Levels: Industry standard below 0.5 EU/mg, with premium suppliers achieving <0.1 EU/mg for injectable-grade material.
• pH Range: Reconstituted solution maintains a pH of 5.5-6.5, optimized for minimal injection site irritation and maximum peptide stability.

Industry data from 2023 indicates that the global GHK-Cu market has grown at a CAGR of 8.2% since 2018, driven by expanding applications in dermatological research and regenerative medicine protocols. Over 60% of bulk buyers now require third-party HPLC and endotoxin certificates before purchase.

Manufacturing & Quality Control

Production of ghk cu peptide injection involves solid-phase peptide synthesis (SPPS) followed by copper chelation under controlled conditions. The process begins with Fmoc-protected amino acids assembled on a resin, followed by cleavage and purification via reverse-phase HPLC. Copper binding is achieved by incubating the tripeptide with copper acetate at a precise 1:1 molar ratio, ensuring complete coordination without free copper ions. Quality control protocols include mass spectrometry verification, amino acid analysis, and heavy metal screening to meet pharmaceutical-grade standards.

• Purification Method: Preparative HPLC with C18 columns achieves >98% purity, removing truncated sequences and unbound copper.
• Third-Party Testing: Independent labs verify peptide content, endotoxin levels, and sterility per USP <71> guidelines.
• Certification Requirements: COA (Certificate of Analysis), MSDS, and batch-specific HPLC chromatograms are standard for B2B transactions.
• Batch Consistency: Manufacturers maintain <2% variation in peptide content across batches, critical for reproducible research outcomes.
• Packaging Integrity: Lyophilized powder is vacuum-sealed in sterile vials with rubber stoppers and aluminum seals, ensuring moisture-free storage.

Commercial Application Scenarios

The ghk cu peptide injection serves diverse B2B needs across cosmetic formulation, laboratory research, and bulk wholesale distribution. In cosmetic manufacturing, it is incorporated into serums and creams at concentrations of 0.1-1% for anti-aging product lines. Laboratory researchers use it in cell culture studies to investigate collagen synthesis and fibroblast activity. Bulk wholesale buyers, including contract manufacturers and research institutions, purchase multi-kilogram quantities for large-scale formulation or clinical trial preparation.

• Cosmetic Formulation: Added to aqueous phase at 0.5% concentration, combined with antioxidants like vitamin C for synergistic effects in anti-aging creams.
• Lab Research: Reconstituted at 1 mg/mL in sterile PBS for in vitro studies on dermal fibroblast proliferation and matrix metalloproteinase inhibition.
• Bulk Wholesale: Supplied as lyophilized powder in 10g, 50g, or 100g containers, with custom reconstitution protocols for injectable-grade solutions.
• Clinical Preparation: Used in compounding pharmacies for customized injectable formulations under strict aseptic conditions.

ghk cu peptide injection VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

Selecting a reliable supplier for ghk cu peptide injection requires careful evaluation of technical specifications and quality assurance practices. Common pitfalls include accepting low-purity material that degrades quickly or lacks proper endotoxin testing. Buyers should prioritize suppliers who provide batch-specific COAs and offer sample testing before bulk orders. Understanding reconstitution protocols and storage requirements is essential to maintain peptide integrity from receipt to final use.

• Common Pitfalls: Purchasing from suppliers without third-party testing, accepting vague purity claims, or ignoring endotoxin levels for injectable applications.
• Selection Standards: Require HPLC chromatograms, endotoxin certificates, and stability data for each batch. Verify copper content via ICP-MS if possible.
• Buyer Checklist: Confirm purity ≥98%, endotoxin <0.5 EU/mg, and packaging integrity. Request a sample for in-house testing before bulk commitment.
• Reconstitution Protocol: Use sterile WFI, avoid vigorous shaking, and store reconstituted solution at 2-8°C for no more than 72 hours.

Core Product Advantages

The ghk cu peptide injection offers distinct benefits for B2B buyers focused on quality and cost performance. High purity ensures maximum bioactivity per milligram, reducing the amount needed for effective formulations. Superior stability minimizes degradation during storage and transport, lowering overall waste. Competitive pricing combined with technical support from experienced manufacturers provides a reliable supply chain for ongoing research or production needs.

• Purity: ≥99% peptide content ensures consistent results in clinical and cosmetic applications, reducing batch-to-batch variability.
• Stability: Lyophilized form maintains potency for 24 months, allowing flexible inventory management without frequent reordering.
• Cost Performance: Bulk pricing at 10g or higher reduces per-gram cost by up to 40% compared to small-volume purchases.
• Technical Support: Manufacturers provide detailed reconstitution guides, stability data, and custom formulation advice for B2B clients.

Frequently Asked Questions

Q: What is the recommended storage condition for ghk cu peptide injection lyophilized powder?
A: Store the lyophilized powder at -20°C in a dry, light-protected environment. Avoid repeated freeze-thaw cycles. Once reconstituted, use within 72 hours when stored at 2-8°C.

Q: How do I verify the purity of ghk cu peptide injection from a supplier?
A: Request a Certificate of Analysis (COA) with HPLC chromatogram showing a single peak at the expected retention time. The purity should be ≥98% for research-grade material. Independent third-party testing is recommended for critical applications.

Q: What endotoxin level is acceptable for injectable-grade ghk cu peptide?
A: For injectable applications, endotoxin levels should be below 0.5 EU/mg, with premium suppliers offering <0.1 EU/mg. Always verify this specification on the COA before use in clinical or research settings.